|
1
|
Lee KW, Bode AM and Dong Z: Molecular
targets of phytochemicals for cancer prevention. Nat Rev Cancer.
11:211–218. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kassie F, Uhl M, Rabot S, Grasl-Kraupp B,
Verkerk R, Kundi M, Chabicovsky M, Schulte-Hermann R and Knasmüller
S: Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline
(IQ)-induced colonic and hepatic preneoplastic lesions in the F344
rat by cruciferous vegetables administered simultaneously with the
carcinogen. Carcinogenesis. 24:255–261. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weng JR, Tsai CH, Kulp SK and Chen CS:
Indole-3-carbinol as a chemopreventive and anti-cancer agent.
Cancer Lett. 262:153–163. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee SH, Min KW, Zhang X and Baek SJ:
3,3-diindolylmethane induces activating transcription factor 3
(ATF3) via ATF4 in human colorectal cancer cells. J Nutr Biochem.
24:664–671. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nachshon-Kedmi M, Yannai S, Haj A and
Fares FA: Indole-3-carbinol and 3,3~-diindolylmethane induce
apoptosis in human prostate cancer cells. Food Chem Toxicol.
41:745–752. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abdelrahim M, Newman K, Vanderlaag K,
Samudio I and Safe S: 3,3-diindolylmethane (DIM) and its
derivatives induce apoptosis in pancreatic cancer cells through
endoplasmic reticulum stress-dependent upregulation of DR5.
Carcinogenesis. 27:717–728. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rahman KW and Sarkar FH: Inhibition of
nuclear translocation of nuclear factor-{kappa}B contributes to
3,3-diindolylmethane-induced apoptosis in breast cancer cells.
Cancer Res. 65:364–371. 2005.PubMed/NCBI
|
|
8
|
Kassouf W, Chintharlapalli S, Abdelrahim
M, Nelkin G, Safe S and Kamat AM: Inhibition of bladder tumor
growth by 1,1-bis(3-indolyl)-1-(p-substituted phenyl)methanes: A
new class of peroxisome proliferator-activated receptor gamma
agonists. Cancer Res. 66:412–418. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gong Y, Firestone GL and Bjeldanes LF:
3,3-diindolylmethane is a novel topoisomerase IIalpha catalytic
inhibitor that induces S-phase retardation and mitotic delay in
human hepatoma HepG2 cells. Mol Pharmacol. 69:1320–1327. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chintharlapalli S, Papineni S, Baek SJ,
Liu S and Safe S: 1,1-Bis(3-indolyl)-1-(p-substituted
phenyl)methanes are peroxisome proliferator-activated receptor
gamma agonists but decrease HCT-116 colon cancer cell survival
through receptor-independent activation of early growth response-1
and nonsteroidal anti-inflammatory drug-activated gene-1. Mol
Pharmacol. 68:1782–1792. 2005.PubMed/NCBI
|
|
11
|
Musgrove EA, Caldon CE, Barraclough J,
Stone A and Sutherland RL: Cyclin D as a therapeutic target in
cancer. Nat Rev Cancer. 11:558–572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jirawatnotai S, Hu Y, Michowski W, Elias
JE, Becks L, Bienvenu F, Zagozdzon A, Goswami T, Wang YE, Clark AB,
et al: A function for cyclin D1 in DNA repair uncovered by protein
interactome analyses in human cancers. Nature. 474:230–234. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alao JP: The regulation of cyclin D1
degradation: Roles in cancer development and the potential for
therapeutic invention. Mol Cancer. 6:242007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vanderlaag K, Samudio I, Burghardt R,
Barhoumi R and Safe S: Inhibition of breast cancer cell growth and
induction of cell death by 1,1-bis(3-indolyl)methane (DIM) and
5,5-dibromoDIM. Cancer Lett. 236:198–212. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chintharlapalli S, R III Smith, Samudio I,
Zhang W and Safe S: 1,1-Bis(3-indolyl)-1-(p-substituted
phenyl)methanes induce peroxisome proliferator-activated receptor
gamma-mediated growth inhibition, transactivation, and
differentiation markers in colon cancer cells. Cancer Res.
64:5994–6001. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu QJ, Yang Y, Vogtmann E, Wang J, Han LH,
Li HL and Xiang YB: Cruciferous vegetables intake and the risk of
colorectal cancer: A meta-analysis of observational studies. Ann
Oncol. 24:1079–1087. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Banerjee S, Kong D, Wang Z, Bao B, Hillman
GG and Sarkar FH: Attenuation of multi-targeted
proliferation-linked signaling by 3,3-diindolylmethane (DIM): From
bench to clinic. Mutat Res. 728:47–66. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Firestone GL and Bjeldanes LF:
Indole-3-carbinol and 3–3-diindolylmethane antiproliferative
signaling pathways control cell-cycle gene transcription in human
breast cancer cells by regulating promoter-Sp1 transcription factor
interactions. J Nutr. 133 Suppl:2448S–2455S. 2003.PubMed/NCBI
|
|
19
|
Hong C, Kim HA, Firestone GL and Bjeldanes
LF: 3,3-Diindolylmethane (DIM) induces a G1 cell cycle arrest in
human breast cancer cells that is accompanied by Sp1-mediated
activation of p21WAF1/CIP1 expression. Carcinogenesis.
23:1297–1305. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vivar OI, Lin CL, Firestone GL and
Bjeldanes LF: 3,3-Diindolylmethane induces a G1 arrest in human
prostate cancer cells irrespective of androgen receptor and p53
status. Biochem Pharmacol. 78:469–476. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Min KW, Zhang X, Imchen T and Baek SJ: A
peroxisome proliferator-activated receptor ligand MCC-555 imparts
anti-proliferative response in pancreatic cancer cells by
PPARgamma-independent up-regulation of KLF4. Toxicol Appl
Pharmacol. 263:225–232. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Li X and Guo B: Chemopreventive
agent 3,3-diindolylmethane selectively induces proteasomal
degradation of class I histone deacetylases. Cancer Res.
70:646–654. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee SH, Bahn JH, Whitlock NC and Baek SJ:
Activating transcription factor 2 (ATF2) controls tolfenamic
acid-induced ATF3 expression via MAP kinase pathways. Oncogene.
29:5182–5192. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Min KW, Wimalasena J and Baek SJ:
Cyclin D1 degradation and p21 induction contribute to growth
inhibition of colorectal cancer cells induced by
epigallocatechin-3-gallate. J Cancer Res Clin Oncol. 138:2051–2060.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sonenberg N and Hinnebusch AG: Regulation
of translation initiation in eukaryotes: Mechanisms and biological
targets. Cell. 136:731–745. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoon CH, Lee ES, Lim DS and Bae YS: PKR, a
p53 target gene, plays a crucial role in the tumor-suppressor
function of p53. Proc Natl Acad Sci USA. 106:7852–7857. 2009.
View Article : Google Scholar : PubMed/NCBI
|
